During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub spoke with Graham Jackson, Newcastle University, Newcastle upon Tyne, UK. He discusses three things to remember when diagnosing patients with monoclonal gammopathy of uncertain significance (MGUS).

When considering diagnosis for MGUS, Jackson outlines the importance of detecting oligosecretory or non-secretory multiple myeloma, assessing risk of progression, and clinical problems associated with certain cases.